# Biosynthesis and characterization of arsenic trioxide (As2O3) nanoparticles and evaluation of their antibacterial activity against multidrug-resistant Escherichia coli

Source: [Biological sciences : nature.com subject feeds](https://www.nature.com/articles/s41598-026-79423-z) · 2026-11-14 · Life
Page: https://themorning.science/story/biosynthesis-and-characterization-of-arsenic-trioxide-as2o3-nanoparticles-and-ev-9371b63eba2565d1
Kind: research · Impact: low

## In brief

- The study reports the biosynthesis of arsenic trioxide (As2O3) nanoparticles.
- The authors characterize the nanoparticles and evaluate their antibacterial activity.
- The tested target is multidrug-resistant Escherichia coli.

## Why it matters

It explores a nanoparticle-based approach against multidrug-resistant bacteria, a growing concern for antibiotic research. The source provides only the title, so the strength of the evidence cannot be assessed here.

## Timeline

- 2026-11-14: Study published in Scientific Reports

## Coverage

- [Biosynthesis and characterization of arsenic trioxide (As2O3) nanoparticles and evaluation of their antibacterial activity against multidrug-resistant Escherichia coli](https://www.nature.com/articles/s41598-026-79423-z) — Biological sciences : nature.com subject feeds, 2026-11-14

Tags: nanoparticles, antibacterial, antimicrobial resistance, escherichia coli, arsenic trioxide

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science